OMS14
OMS14 is exhibits inhibitory activity for phosphoinositide 3-kinase γ (PI3Kγ) and PIK3CD/PIK3R1, which inhibits 19% PI3Kγ and 65% PIK3CD/PIK3R1 activity at 100 μM. OMS14 exhibits anticancer efficacy in various cancer cells[1].
Product Specifications
UNSPSC
12352005
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/oms14.html
Purity
99.09
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(CN1CCN(CC(NC2=CC=C([N+]([O-])=O)C=C2)=O)CC1)NC3=NC4=C(S3)C=CC=C4
Molecular Formula
C21H22N6O4S
Molecular Weight
454.50
References & Citations
[1]Salih O M, et al., Novel 2-Aminobenzothiazole Derivatives: Docking, Synthesis, and Biological Evaluation as Anticancer Agents[J]. ACS Omega, 2024.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kγ
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Adenosine Monophosphate Deaminase 3 (AMPD3) (AMPD3/901), CF647 conjugate, 0.1mg/mL
Uncoated Human TWEAK (Tumour Necrosis Factor Related Weak Inducer of Apoptosis) ELISA Kit
Uncoated Human TWEAK (Tumour Necrosis Factor Related Weak Inducer of Apoptosis) ELISA Kit
